These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 26934697)

  • 21. Screening the Medicines for Malaria Venture Pathogen Box for invasion and egress inhibitors of the blood stage of Plasmodium falciparum reveals several inhibitory compounds.
    Dans MG; Weiss GE; Wilson DW; Sleebs BE; Crabb BS; de Koning-Ward TF; Gilson PR
    Int J Parasitol; 2020 Mar; 50(3):235-252. PubMed ID: 32135179
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Medicines for Malaria Venture Malaria Box contains inhibitors of protein secretion in Plasmodium falciparum blood stage parasites.
    Looker O; Dans MG; Bullen HE; Sleebs BE; Crabb BS; Gilson PR
    Traffic; 2022 Sep; 23(9):442-461. PubMed ID: 36040075
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cyclin-dependent protein kinases as therapeutic drug targets for antimalarial drug development.
    Waters NC; Geyer JA
    Expert Opin Ther Targets; 2003 Feb; 7(1):7-17. PubMed ID: 12556199
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plasmodium falciparum Calcium-Dependent Protein Kinase 4 is Critical for Male Gametogenesis and Transmission to the Mosquito Vector.
    Kumar S; Haile MT; Hoopmann MR; Tran LT; Michaels SA; Morrone SR; Ojo KK; Reynolds LM; Kusebauch U; Vaughan AM; Moritz RL; Kappe SHI; Swearingen KE
    mBio; 2021 Dec; 12(6):e0257521. PubMed ID: 34724830
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Imidazopyridazines as potent inhibitors of Plasmodium falciparum calcium-dependent protein kinase 1 (PfCDPK1): Preparation and evaluation of pyrazole linked analogues.
    Large JM; Osborne SA; Smiljanic-Hurley E; Ansell KH; Jones HM; Taylor DL; Clough B; Green JL; Holder AA
    Bioorg Med Chem Lett; 2013 Nov; 23(21):6019-24. PubMed ID: 24035097
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Temperature does matter-an additional dimension in kinase inhibitor development.
    Strauch M; Heyd F
    FEBS J; 2021 May; 288(10):3148-3153. PubMed ID: 32946682
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 5-Aminopyrazole-4-carboxamide analogues are selective inhibitors of Plasmodium falciparum microgametocyte exflagellation and potential malaria transmission blocking agents.
    Huang W; Hulverson MA; Zhang Z; Choi R; Hart KJ; Kennedy M; Vidadala RSR; Maly DJ; Van Voorhis WC; Lindner SE; Fan E; Ojo KK
    Bioorg Med Chem Lett; 2016 Nov; 26(22):5487-5491. PubMed ID: 27780638
    [TBL] [Abstract][Full Text] [Related]  

  • 28. One-pot, multi-component synthesis and structure-activity relationships of peptoid-based histone deacetylase (HDAC) inhibitors targeting malaria parasites.
    Diedrich D; Stenzel K; Hesping E; Antonova-Koch Y; Gebru T; Duffy S; Fisher G; Schöler A; Meister S; Kurz T; Avery VM; Winzeler EA; Held J; Andrews KT; Hansen FK
    Eur J Med Chem; 2018 Oct; 158():801-813. PubMed ID: 30245402
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Parasite and Host Erythrocyte Kinomics of Plasmodium Infection.
    Adderley J; Williamson T; Doerig C
    Trends Parasitol; 2021 Jun; 37(6):508-524. PubMed ID: 33593681
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of the anti-malarial activity and cytotoxicity of 2,4-diamino-pyrimidine-based kinase inhibitors.
    Phuangsawai O; Beswick P; Ratanabunyong S; Tabtimmai L; Suphakun P; Obounchoey P; Srisook P; Horata N; Chuckowree I; Hannongbua S; Ward SE; Choowongkomon K; Gleeson MP
    Eur J Med Chem; 2016 Nov; 124():896-905. PubMed ID: 27668758
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A New Thienopyrimidinone Chemotype Shows Multistage Activity against Plasmodium falciparum, Including Artemisinin-Resistant Parasites.
    Bosson-Vanga H; Primas N; Franetich JF; Lavazec C; Gomez L; Ashraf K; Tefit M; Soulard V; Dereuddre-Bosquet N; Le Grand R; Donnette M; Mustière R; Amanzougaghene N; Tajeri S; Suzanne P; Malzert-Fréon A; Rault S; Vanelle P; Hutter S; Cohen A; Snounou G; Roques P; Azas N; Lagardère P; Lisowski V; Masurier N; Nguyen M; Paloque L; Benoit-Vical F; Verhaeghe P; Mazier D
    Microbiol Spectr; 2021 Oct; 9(2):e0027421. PubMed ID: 34724729
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of β-hematin inhibitors in the MMV Malaria Box.
    Fong KY; Sandlin RD; Wright DW
    Int J Parasitol Drugs Drug Resist; 2015 Dec; 5(3):84-91. PubMed ID: 26150923
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Screening a protein kinase inhibitor library against Plasmodium falciparum.
    Hallyburton I; Grimaldi R; Woodland A; Baragaña B; Luksch T; Spinks D; James D; Leroy D; Waterson D; Fairlamb AH; Wyatt PG; Gilbert IH; Frearson JA
    Malar J; 2017 Nov; 16(1):446. PubMed ID: 29115999
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Transport proteins as drug targets in Plasmodium falciparum. New perspectives in the treatment of malaria].
    Ellekvist P; Colding H
    Ugeskr Laeger; 2006 Mar; 168(13):1314-7. PubMed ID: 16579884
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A New Set of Chemical Starting Points with Plasmodium falciparum Transmission-Blocking Potential for Antimalarial Drug Discovery.
    Almela MJ; Lozano S; Lelièvre J; Colmenarejo G; Coterón JM; Rodrigues J; Gonzalez C; Herreros E
    PLoS One; 2015; 10(8):e0135139. PubMed ID: 26317851
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of tyrosine kinase inhibitors that halt Plasmodium falciparum parasitemia.
    Kesely K; Noomuna P; Vieth M; Hipskind P; Haldar K; Pantaleo A; Turrini F; Low PS
    PLoS One; 2020; 15(11):e0242372. PubMed ID: 33180822
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Substrate-analogous inhibitors exert antimalarial action by targeting the Plasmodium lactate transporter PfFNT at nanomolar scale.
    Golldack A; Henke B; Bergmann B; Wiechert M; Erler H; Blancke Soares A; Spielmann T; Beitz E
    PLoS Pathog; 2017 Feb; 13(2):e1006172. PubMed ID: 28178358
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Functional screening of selective mitochondrial inhibitors of Plasmodium.
    Gomez-Lorenzo MG; Rodríguez-Alejandre A; Moliner-Cubel S; Martínez-Hoyos M; Bahamontes-Rosa N; Gonzalez Del Rio R; Ródenas C; Fuente J; Lavandera JL; García-Bustos JF; Mendoza-Losana A
    Int J Parasitol Drugs Drug Resist; 2018 Aug; 8(2):295-303. PubMed ID: 29775797
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular dynamics simulations and biochemical characterization of Pf14-3-3 and PfCDPK1 interaction towards its role in growth of human malaria parasite.
    Jain R; Dey P; Gupta S; Pati S; Bhattacherjee A; Munde M; Singh S
    Biochem J; 2020 Jun; 477(12):2153-2177. PubMed ID: 32484216
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Protein kinases as targets for antimalarial intervention: Kinomics, structure-based design, transmission-blockade, and targeting host cell enzymes.
    Doerig C; Billker O; Pratt D; Endicott J
    Biochim Biophys Acta; 2005 Dec; 1754(1-2):132-50. PubMed ID: 16271522
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.